April 25, 2018 / 11:20 AM / a month ago

BRIEF-Corvidia Therapeutics Secures $60 Mln In Series B Funding To Accelerate Clinical Work

April 25 (Reuters) -

* CORVIDIA THERAPEUTICS SECURES $60 MILLION IN SERIES B FUNDING TO ACCELERATE CLINICAL WORK

* CORVIDIA THERAPEUTICS INC, A CLINICAL STAGE BIOTECHNOLOGY COMPANY, SAYS VENROCK LED THE $60 MILLION SERIES B FINANCING Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below